No categories for this tab

About Us

About PharmaCountry
How It Works
Partnerships
Sustainability
Contact Us

For Buyers

Search Products
Search Services
Find Suppliers
Find Jobs
Find Seekers
Help Center
FAQ
Buyer Protection

For Sellers/Service Providers

Start Selling
Seller Guide
Pricing Plans
Advertising
Seller Support

Top Categories

Active Pharmaceutical Ingredients (APIs)
Finished Dosage Forms
Manufacturing Equipment & Utilities
Excipients & Additives
View All Categories

Stay Connected

[email protected]

24/7 Customer Support

Trusted B2B Platform

SSL Secure Transactions Verified Suppliers Quality Assured B2B Certified Global Network

© 2026 PharmaCountry. All rights reserved.

Privacy Policy Terms of Service Cookie Policy

Ondansevit 8mg/4ml | Pharmacountry

Products
Finished Dosage Forms
Injectables & Parenterals
Large Volume Parenterals (LVP)/IV Infusions

Ondansevit 8mg/4ml

BB

Marketing Authorization Holder · Finished Dosage FormsBelgium

Ratings

(0)

(0)

(0)

(0)

(0)

Leave your rating & comment

Comments

Filters:

Sort by:

No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product

Basic Information

Category

Finished Dosage Forms

Subcategory & Sub-subcategory

Injectables & Parenterals / Large Volume Parenterals (LVP)/IV Infusions

Trade Type

Sell

Product Name

Ondansevit 8mg/4ml

Details

Each 4 mL solution containing: Ondansetron (in the form of Ondansetron hydrochlorid dihydrate)

Substance

Manufacturer(s)

Laboratorios Normon, S.A - Spain

Registered Market

Viet Nam

Specifications

Dosage Form: Solution injection/infusion
Packaging: Box 50 ampoule x 4 mL
Strength: 8mg
Standards: In-house standard
Shelf Life: 36 month

Documents

Drug Marketing Authorization Number

Document No.: 840110985324

Issue Date: Oct 14, 2024

Expiry Date: Oct 14, 2029

Note: 698/QĐ-QLD | 122